Previous 10 | Next 10 |
TC BioPharm to Host Shareholder Update Call PR Newswire Conference Call to be held on Monday, February 20 th , 2023 at 10:00 am ET EDINBURGH, Scotland , Jan. 20, 2023 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Compan...
TC Biopharm ( NASDAQ: TCBP ) has received Nasdaq notice indicating the company has not regained compliance with the rule of $35M minimum market value of listed securities. The company on July 15,2022 had received written Nasdaq notice indicating that the company wa...
Palm Beach, FL – January 19, 2023 – FinancialNewsMedia.com News Commentary – Gamma Delta T Cell Therapy represents one of the most promising T Cell therapies in clinical development. The introduction of T cell-based immunotherapy has greatly revolutionized the par...
TC BioPharm Receives Notice of Non-compliance with NASDAQ's Listing Rule 5550(b)(1) PR Newswire EDINBURGH, Scotland , Jan. 19, 2023 /PRNewswire/ -- TC Biopharm (Holdings) PLC ("TC Biopharm" or the "Company") (NASDAQ: TCBP) (NASDAQ: TCBPW), has received writte...
TC Biopharm ( NASDAQ: TCBP ) is trading 18.5% higher premarket after it announced a strategic collaboration with The University of Texas MD Anderson Cancer Center to test on how gamma-delta T cells work in oncology settings. Under the collaboration, MD Anderson's clinical tria...
TC BioPharm Announces Strategic Collaboration to Advance Gamma Delta T Cells in Oncology PR Newswire Endeavor to focus on expanding understanding of gamma-delta T cells in oncological settings EDINBURGH, Scotland , Jan. 17, 2023 /PRNewswire/ -- TC B...
TC Biopharm press release ( NASDAQ: TCBP ): 1H GAAP EPS of $1.13. Revenue of $1.2M. Cash and cash equivalents were £6.0 million or $7.3 million as of June 30, 2022 compared to £1.6 million as of December 31, 2021. For further details see: TC Biopharm GAAP E...
TC BioPharm Reports First Half 2022 Financial Results and Provides Shareholder Update PR Newswire Dosed first three patients within Phase 2b clinical trial of OmnImmune®, an allogeneic unmodified cell therapy focused on treating Acute Myeloid Leukemia (AML). ...
TC BioPharm Announces Closing of $7.35 Million Private Placement PR Newswire EDINBURGH, Scotland , Nov. 30, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (Nasdaq: TCBP) (Nasdaq: TCBPW), a clinical stage biotechnology company dev...
TC BioPharm Announces $7.35 Million Private Placement PR Newswire EDINBURGH, Scotland , Nov. 28, 2022 /PRNewswire/ -- TC BioPharm (Holdings) PLC ("TC BioPharm" or the "Company") (Nasdaq: TCBP) (Nasdaq: TCBPW), a clinical stage biotechnology company d...
News, Short Squeeze, Breakout and More Instantly...
TC BioPharm (Holdings) plc Company Name:
TCBP Stock Symbol:
NASDAQ Market:
Shares of Reliance Global Group, Inc. (NASDAQ: RELI) fell sharply in today’s pre-market trading after reporting financial results for ...
2024-04-05 06:01:00 ET 3 Green Flags to Look for When Finding Penny Stocks to Buy Identifying promising penny stocks for investment requires discernment, focusing on specific positive indicators that suggest a stock may be poised for growth. Among these green flags, strong financial hea...
U.S. stocks turned lower toward the end of trading, with the Dow Jones index falling more than 200 points on Thursday. The Dow traded down 0.5...